Cara Therapeutics Inc (CARA)
0.3279
-0.01
(-3.84%)
USD |
NASDAQ |
Nov 13, 16:00
0.3278
0.00 (0.00%)
After-Hours: 20:00
Cara Therapeutics Net Income (TTM): -111.08M for June 30, 2024
Net Income (TTM) Chart
Historical Net Income (TTM) Data
| Date | Value |
|---|---|
| June 30, 2024 | -111.08M |
| March 31, 2024 | -122.54M |
| December 31, 2023 | -118.51M |
| September 30, 2023 | -116.52M |
| June 30, 2023 | -111.66M |
| March 31, 2023 | -84.39M |
| December 31, 2022 | -85.47M |
| September 30, 2022 | -88.52M |
| June 30, 2022 | -66.35M |
| March 31, 2022 | -92.89M |
| December 31, 2021 | -88.44M |
| September 30, 2021 | 23.85M |
| June 30, 2021 | 8.354M |
| March 31, 2021 | 14.03M |
| December 31, 2020 | 8.41M |
| September 30, 2020 | -99.11M |
| June 30, 2020 | -115.44M |
| March 31, 2020 | -113.34M |
| December 31, 2019 | -106.37M |
| September 30, 2019 | -98.41M |
| June 30, 2019 | -84.97M |
| March 31, 2019 | -79.21M |
| Date | Value |
|---|---|
| December 31, 2018 | -74.01M |
| September 30, 2018 | -67.54M |
| June 30, 2018 | -60.58M |
| March 31, 2018 | -52.69M |
| December 31, 2017 | -58.12M |
| September 30, 2017 | -65.92M |
| June 30, 2017 | -65.02M |
| March 31, 2017 | -68.79M |
| December 31, 2016 | -57.28M |
| September 30, 2016 | -44.84M |
| June 30, 2016 | -38.08M |
| March 31, 2016 | -30.69M |
| December 31, 2015 | -24.69M |
| September 30, 2015 | -19.33M |
| June 30, 2015 | -21.09M |
| March 31, 2015 | -19.05M |
| December 31, 2014 | -17.74M |
| September 30, 2014 | -15.67M |
| June 30, 2014 | -13.70M |
| March 31, 2014 | -4.714M |
| December 31, 2013 | -3.963M |
| September 30, 2013 | -3.667M |
Net Income Definition
Net Income is the total amount of profit earned by a company. This metric boils down to the overall profit that is left from the revenue that a company receives after taking out various operational line items like cost of goods sold, income tax expense, SG&A expense, etc. Eventually, all companies would want to have a consistent positive and growing net income, so that this can be used for various purposes like reinvesting into the company, paying off debt, and potentially paying out dividends to shareholders.
Net Income (TTM) Range, Past 5 Years
-122.54M
Minimum
Mar 2024
23.85M
Maximum
Sep 2021
-77.16M
Average
-92.89M
Median
Mar 2022
Net Income (TTM) Benchmarks
| Perspective Therapeutics Inc | -59.02M |
| Alaunos Therapeutics Inc | -19.13M |
| Oragenics Inc | -19.52M |
| Cocrystal Pharma Inc | -17.93M |
| Citius Pharmaceuticals Inc | -38.29M |